Abstract
Summary
GlobalData' s "Pipeline Products and Technology Analysis Report" is an
essential source of information and analysis on pipeline medical devices,
which are expected to bring significant shift to the prevalent market
landscape. We keep our subscribers abreast of the very latest technological
developments by providing them with our independent and unbiased judgment on
the implications of each development within the industry. While the objective
is to review specific pipeline devices and technologies, the report also
provides a holistic overview of the existing products, the market structure
and the competitive landscape.
Scope
- Analysis and review of the key pipeline devices that are likely to impact
the treatment landscape globally;
- Independent analysis of the product details, indication details and
clinical trial status with projections on the market potential;
- Review of existing competing technologies and the competitive landscape;
- Review and analysis of the trends, drivers and restraints shaping and
defining the markets that the products are being targeted in;
- In-depth analysis of the device-specific developments, strategic
partnerships and other details expected to influence the launch and market
penetration.
Reasons to buy
- Effectively plan your M&A and partnership strategies by identifying
companies with the most promising pipeline;
- Plan in-licensing and out-licensing opportunities through review of
pipeline products and technologies;
- Identify emerging players with potentially strong product portfolio and
create effective counter-strategies to gain competitive advantage; and
- Stay ahead of competition by understanding the changing competitive
landscape in specific geographies.
Table of Contents
1 Table of Contents 2
- 1.1 List of Tables 4
- 1.2 List of Figures 5
2 Introduction 6
- 2.1 What Is This Report About? 6
- 2.2 Summary 6
3 Atrial Fibrillation Market Overview 8
- 3.1 Global Atrial Fibrillation Market Analysis 8
- 3.2 Atrial Fibrillation Trend Assessment 9
- 3.2.1 Market Drivers 9
- 3.2.2 Market Restraints 10
- 3.3 Competitive Landscape 10
- 3.4 Clinical Trial Comparisons 11
- 3.4.1 STOP AF Clinical Trial: 11
- 3.4.2 Tailored Treatment of Permanent Atrial Fibrillation (TTOP AF),
Clinical Trial 11
- 3.4.3 Multi-Array Ablation of Pulmonary Veins for Paroxysmal Atrial
Fibrillation" or MAP-PAF Trial 11
- 3.5 Technology Description 12
- 3.5.1 Cyberknife Robotic Radio Surgery Technology 12
- 3.5.2 Instinctive Fine Force Technology 12
- 3.5.3 Ensite NavX Navigation and Visualization Technology 12
- 3.6 Energy Source Comparisons: 13
- 3.7 Atrial Fibrillation Pipeline Products 13
- 3.7.1 Pipeline Products using Cryo Energy 14
- 3.7.2 Pipeline Products using RF Energy 22
4 Outlook and Implications 28
5 Global Atrial Fibrillation Pipeline Product Summary 29
6 Global Atrial Fibrillation Pipeline Trial Summary 31
7 Appendix 33
- 7.1 Research Methodology 33
- 7.2 Coverage 33
- 7.3 Secondary Research 34
- 7.4 Primary Research 35
- 7.5 Models 35
- 7.6 Forecasts 36
- 7.7 Expert Panels 36
- 7.8 GlobalData Consulting 36
- 7.9 Contact Us 36
- 7.10 Disclaimer 37
| 
